Shots: Medical Developments International (MVP) to receive up to $32.5M (AUD $45.8M) as total deal value plus $15M upfront and additional sales-based milestones payments MVP will fund the regulatory process […]readmore
Tags : License Agreement
Shots: Verastem will receive an upfront of $15M with up to $30M for development milestones, additional sales milestones and double-digit royalties on net sales of Copiktra (duvelisib) CSPC to get […]readmore
Shots: The agreement will focus on commercialization of kidney organoid technology, for generation of human pluripotent stem cell-derived kidney organoids This technology enables the growth of organoids/ mini-organs, having key […]readmore